Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

You might need to brush your hair to go ‘camera on’, but showing your face can forge trust. Author Andrew Brodsky on what ...

Health insurers process more than five billion payment claims annually, federal figures show. About 850 million are denied, ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...